RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025

(NasdaqGM:RXST), ALISO VIEJO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) — (Nasdaq: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the third quarter of 2025 after the market close on Wednesday, November 5, 2025. The company's management will discuss […]

Churchill Downs Incorporated Announces New Victory Run Capital Investment at Churchill Downs Racetrack

(NASDAQ:CHDN), LOUSVILLE, Ky., Oct. 22, 2025 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today a growth project called Victory Run, an exciting new structure on the first turn of the Churchill Downs Racetrack between the First Turn Club and the Skye Terrace. Victory Run will replace uncovered, ground-level box

OPKO Health to Report Third Quarter 2025 Financial Results on October 29

(NASDAQ:OPK), MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO's senior management will provide a business update and discuss results as

EQV Ventures Acquisition Corp. Announces New Ticker Symbol “FTW” to Reflect Proposed Business Combination with Presidio

(NYSE:EQVU),(NYSE:EQV), Fort Worth, TX, Oct. 22, 2025 (GLOBE NEWSWIRE) — EQV Ventures Acquisition Corp. (NYSE: EQV; EQV U; EQV WS) (“EQV”), a special purpose acquisition company sponsored by EQV Group, today announced that it will change the ticker symbol of its Class A ordinary shares on the New York Stock Exchange (NYSE) from “EQV” to

Coherent Corp. Announces Timing of FY2026 First Quarter Earnings Release

(NYSE:COHR), SAXONBURG, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR) (“Coherent,” “We,” or the “Company”), a global leader in photonics, announced today that it will release its financial results for the quarter ended September 30, 2025, on Wednesday, November 5, after the New York Stock Exchange closes. The release will be followed

Texas Capital Bancshares, Inc. Announces Third Quarter 2025 Results

(NASDAQ:TCBI), Third quarter 2025 ROAA of 1.30% Record-level net income of $105.2 million, record-level net income available to common stockholders of $100.9 million and record-level diluted earnings per share of $2.18 for the third quarter of 2025 Record-level Book Value and record-level Tangible Book Value(2) per share of $73.05 and $73.02, respectively Growth in capital

Kaltura to Announce Financial Results for Third Quarter 2025 on Monday, November 10, 2025

(NASDAQ:KLTR), NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — Kaltura (Nasdaq: KLTR), the AI Video Experience Cloud, today announced it will release its third quarter financial results for the period ended September 30, 2025, after market close on Monday, November 10, 2025. Management will host a conference call to review the Company's third quarter 2025

Covenant Logistics Group Announces Third Quarter 2025 Financial and Operating Results

(NYSE:CVLG), CHATTANOOGA, Tenn., Oct. 22, 2025 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NYSE: CVLG) (“Covenant” or the “Company”) announced today financial and operating results for the third quarter ended September 30, 2025. The Company's conference call to discuss the quarter will be held at 10:00 A.M. Eastern Time on Thursday, October 23, 2025. Chairman

red violet to Announce Third Quarter 2025 Financial Results on November 5, 2025

(NASDAQ:RDVT), BOCA RATON, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, announced today that it will report its financial results for the third quarter ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, November 5, 2025. The Company will

Generation Bio Announces CEO Transition

(NASDAQ:GBIO), • Geoff McDonough, MD to step down as CEO & President and become Chair of the Company's Board of Directors • Current Chief Legal Officer Yalonda Howze, JD named Interim CEO & President CAMBRIDGE, MASS., Oct. 22, 2025 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company working to change what's possible

Scroll to Top